| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 8 buys and 4 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2019 | Stonehouse Jon P80 | President &CEO | Buy | 50,000 | $1.45 | $72,500.00 | +6.9% | |
| Nov 18, 2019 | Sniecinski Megan | Chief Business Officer | Buy | 45,000 | $1.45 | $65,250.00 | New | |
| Nov 18, 2019 | Barnes Alane P70 | Senior VP, Chief Legal Officer | Buy | 20,000 | $1.45 | $29,000.00 | +24.4% | |
| Nov 18, 2019 | Ingram Robert Alexander | Director | Buy | 20,000 | $1.45 | $29,000.00 | +71.2% | |
| Nov 18, 2019 | Hutson Nancy J58 | Director | Buy | 10,000 | $1.45 | $14,500.00 | +23.2% | |
| Nov 18, 2019 | Heggie Theresa | Director | Buy | 5,000 | $1.45 | $7,250.00 | +299.0% | |
| Nov 18, 2019 | Aselage Steve80 | Director | Buy | 15,000 | $1.45 | $21,750.00 | +224.8% | |
| May 22, 2019 | Aselage Steve80 | Director | Buy | 3,000 | $3.57 | $10,710.00 | +150.0% | |
| May 17, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 9,750 | $7.65 | $74,595.00 | -3.7% | |
| May 15, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 11,750 | $7.81 | $91,710.00 | -4.3% |